Nicholas McGranahan

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Nicholas McGranahan

Aug 18, 2024, 06:12 | Blog

Biagio Ricciuti: KEAPness signature outperforms deleterious KEAP1 mutations in predicting ICI efficacy in NSCLC

Biagio Ricciuti shared on X: "Sharing our latest effort out in Clinical Cancer Research! This multicenter…

Jul 28, 2024, 14:24 | Insight

10 papers suggested by Wafik S. El-Deiry

Wafik S. El-Deiry, Director of the Legorreta Cancer Center of Brown University and Associate Dean for…

Jul 14, 2024, 06:26 | Insight

Daniele Marinelli: NRF2-driven transcription in NSCLC

Daniele Marinelli, PhD student at the Sapienza University of Rome, shared a post on X…

May 2, 2024, 14:25 | Insight

Fabrice Andre: A nice seminar around Precision Medicine

Vivek Subbiah shared a post by Fabrice Andre, Head of Research Division at Gustave Roussy…

Apr 14, 2024, 07:35 | Drugs

Charles Swanton: What is the role of the TME in lung cancer evolution?

Charles Swanton, Professor at University College London Cancer Institute, shared on X/Twitter: "What is the role…

Apr 8, 2024, 22:24 | Insight

NSCLC's Immune Landscape: A Comprehensive Study of the Tumor Microenvironment

A recent study, “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical…

Dec 6, 2023, 11:54 | Insight

Nicholas McGranahan: Welcome to the CONIPHER TREEtorial, just in time for Christmas

Nicholas McGranahan, Group leader at the CRUK-UCL Lung Cancer Centre of Excellence, shared on X/Twitter:…

All: 7 Posts: 1 - 100